Holen Sie sich die Stockscreener-App
1.02
0.00%
0.00
Handel nachbörslich:
1.02
Schlusskurs vom Vortag:
$1.02
Offen:
$1.0001
24-Stunden-Volumen:
64,710
Relative Volume:
0.08
Marktkapitalisierung:
$4.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.78M
KGV:
-0.0239
EPS:
-42.6996
Netto-Cashflow:
$-4.67M
1W Leistung:
+6.23%
1M Leistung:
+7.30%
6M Leistung:
-27.14%
1J Leistung:
-14.29%
1-Tages-Spanne:
$0.98
$1.04
1-Wochen-Bereich:
$0.952
$1.04
52-Wochen-Spanne:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Firmenname
Clearmind Medicine Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CMND mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.02 | 5.38M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten
Can Clearmind Medicine Inc. rally from current levelsQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Trend analysis for Clearmind Medicine Inc. this weekWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
How Clearmind Medicine Inc. stock performs during market volatilityIndex Update & Weekly High Return Stock Forecasts - Newser
Institutional scanner results for Clearmind Medicine Inc.Portfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Risk vs reward if holding onto Clearmind Medicine Inc.Weekly Signal Report with Trend Summary - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
Should you wait for a breakout in Clearmind Medicine Inc.Volatility Analysis and Entry Risk Mapping - Newser
Clearmind Medicine Inc. stock trendline breakdownFree Accurate Technical Trend Reversal Picks - Newser
Clearmind Medicine Inc. stock chart pattern explainedDaily Technical Chart Pattern Analysis Report - Newser
Exit strategy if you’re trapped in Clearmind Medicine IncFree Smart Trade Plans With Risk Protection - Newser
What makes Clearmind Medicine Inc. stock price move sharplyFree Reliable Chart-Based Trade Entries - Newser
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - MarketScreener
Clearmind Medicine Inc. stock retracement – recovery analysis5-Year Price Trend Summary and Analysis - Newser
Can a trend reversal in Clearmind Medicine Inc. lead to recoveryEntry Zone Forecast for Momentum Trading - Newser
Short interest data insights for Clearmind Medicine Inc.Entry Confirmation Based on Volatility Analysis - Newser
Can you recover from losses in Clearmind Medicine Inc.Daily Stock Watch Summary with Key Insights - Newser
Will Clearmind Medicine Inc. benefit from macro trendsMomentum-Based Prediction for Quick Returns - Newser
Can volume confirm reversal in Clearmind Medicine Inc.Real Market Tracker with Price Action Tools - Newser
Is it time to cut losses on Clearmind Medicine Inc.Buy List With Technical Entry Triggers - Newser
Published on: 2025-08-09 23:23:05 - Newser
How to use a screener to detect Clearmind Medicine Inc. breakoutsTrend Analysis for Safer Market Entries - Newser
How Clearmind Medicine Inc. stock reacts to Fed policy changesHigh Win Rate Trading Opportunities Detected - metal.it
Clearmind Medicine Inc. stock outlook for YEARTechnical Insight Guide for Safer Trades - Newser
SciSparc-Clearmind collab leads to international patent application - TipRanks
Clearmind announces publication of international patent application under PCT - TipRanks
Clearmind announces patent application for metabolic syndrome treatment - Investing.com
Clearmind announces patent application for metabolic syndrome treatment By Investing.com - Investing.com South Africa
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Breakthrough Obesity Treatment Patent Targets One-Third of US Adults with Metabolic Syndrome - Stock Titan
Finanzdaten der Clearmind Medicine Inc-Aktie (CMND)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):